To find additional susceptibility loci for lung cancer, we tested promising associations from our previous genome-wide association study (GWAS) 1 of lung cancer in the Chinese population in an extended validation sample size of 7,436 individuals with lung cancer (cases) and 7,483 controls. We found genome-wide significant (P < 5.0 × 10 −8 ) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10 −10 ), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10 −9 ) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10 −8 ). We also found consistent associations for rs247008 at 5q31.1 (IL3-CSF2-P4HA2, P = 7.68 × 10 −8 ) and rs9439519 at 1p36.32 (AJAP1-NPHP4, P = 3.65 × 10 −6 ). Four of these loci showed evidence for interactions with smoking dose (P = 1.72 × 10 −10 , P = 5.07 × 10 −3 , P = 6.77 × 10 −3 and P = 4.49 × 10 −2 for rs2895680, rs4809957, rs247008 and rs9439519, respectively). These results advance our understanding of lung cancer susceptibility and highlight potential pathways that integrate genetic variants and smoking in the development of lung cancer.
To find additional susceptibility loci for lung cancer, we tested promising associations from our previous genome-wide association study (GWAS) 1 of lung cancer in the Chinese population in an extended validation sample size of 7,436 individuals with lung cancer (cases) and 7,483 controls. We found genome-wide significant (P < 5.0 × 10 −8 ) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10 −10 ), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10 −9 ) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10 −8 ). We also found consistent associations for rs247008 at 5q31.1 (IL3-CSF2-P4HA2, P = 7.68 × 10 −8 ) and rs9439519 at 1p36.32 (AJAP1-NPHP4, P = 3.65 × 10 −6 ). Four of these loci showed evidence for interactions with smoking dose (P = 1.72 × 10 −10 , P = 5.07 × 10 −3 , P = 6.77 × 10 −3 and P = 4.49 × 10 −2 for rs2895680, rs4809957, rs247008 and rs9439519, respectively). These results advance our understanding of lung cancer susceptibility and highlight potential pathways that integrate genetic variants and smoking in the development of lung cancer.
Thus far, GWAS has achieved considerable success in deciphering the genetic basis of lung cancer in both European-ancestry and Asian populations [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . We recently reported a multistage GWAS of lung cancer in the Chinese population, with two newly identified (13q12.12 and 22q12.2) and two replicated loci (3q28 and 5p15.33) for lung cancer susceptibility 1 . Although previous GWAS efforts have provided valuable clues regarding the etiology of lung cancer, additional genetic factors remain to be discovered.
Therefore, we conducted an evaluation of promising associations in an extended two-stage replication consisting of 7,436 cases and 7,483 controls, focusing on SNPs with P values ranging from 10 −4 to 10 −6 in our initial GWAS ( Supplementary Fig. 1 and Supplementary Table 1) . A total of 95 SNPs met these criteria (Online Methods). We used linkage disequilibrium (LD) analyses to reduce the number of SNPs for genotyping and selected for further analysis those with the lowest P values among multiple SNPs in high LD (r 2 ≥ 0.8), yielding 67 SNPs for genotyping in the first replication stage (Supplementary Table 2 ). We excluded from further analysis the remaining 28 SNPs (Supplementary Table 3 ), which were in high LD with these 67 SNPs. The results from the 67 SNPs in the GWAS and replication studies are shown in Supplementary Tables 2 and 4. Among these 67 SNPs, 6 were consistently replicated in the first-stage replication of 2,283 cases and 2,243 controls with the same direction of significant associations as in the GWAS (Supplementary Table 4 and Supplementary  Fig. 1 ). The second-stage replication of 5,153 cases and 5,240 controls further verified the significant associations with five loci at 10p14 (rs1663689), 5q32 (rs2895680), 20q13.2 (rs4809957), 5q31.1 (rs247008) and 1p36.32 (rs9439519) ( Table 1 and Supplementary  Table 4 ). In the combined analysis, we observed associations for rs1663689 (P combined = 2.84 × 10 −10 , odds ratio (OR) = 0.88) at 10p14, rs2895680 (P combined = 6.60 × 10 −9 , OR = 1.14) at 5q32, rs4809957 (P combined = 1.20 × 10 −8 , OR = 1.13) at 20q13.2, rs247008 (P combined = 7.68 × 10 −8 , OR = 0.89) at 5q31.1 and rs9439519 (P combined = 3.65 × 10 −6 , OR = 1.11) at 1p36.32 ( Table 1 and Supplementary Table 5) , three of which (rs1663689, rs2895680 and rs4809957) achieved genome-wide significance (P = 5.0 × 10 −8 ).
After imputation, we tested 13,849 imputed SNPs (imputed r 2 > 0.5, minor allele frequency (MAF) > 0.05, located in the 1,000 kb around each side of the five most significant marker SNPs) (Fig. 1) . For 10p14, a series of SNPs were in high LD with rs1663689 (r 2 = 0.826 to r 2 = 1, P = 8.76 × 10 −5 to P = 6.00 × 10 −5 ) (Fig. 1a and Supplementary Table 6 ).
Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population 8 9 6 VOLUME 44 | NUMBER 8 | AUGUST 2012 Nature GeNetics l e t t e r s Similarly, we found several SNPs in high LD with rs4809957 at 20q13.2 (r 2 = 0.967 to r 2 = 1, P = 7.08 × 10 −5 to P = 5.54 × 10 −5 ), including one SNP that was genotyped in the GWAS (rs1570669) and one synonymous SNP in exon 6 of CYP24A1 (rs2296239) (Fig. 1c and Supplementary Table 6 ). rs9439526, rs9439527 and rs9439528 at 1p36.32 were in high LD with rs9439519 (r 2 = 0.855, P = 7.91 × 10 −4 to P = 4.22 × 10 −4 ), and rs9439527 had also been directly genotyped in the GWAS (Fig. 1e) . Although we detected residual associations at many SNPs in the regions for 5q31.1 and 5q32, the most significant signal occurred at the two index SNPs, rs247008 at 5q31.1 and rs2895680 at 5q32 (Fig. 1b,d and Supplementary Table 6) .
Stratification analyses showed heterogeneities in the ORs for rs2895680 among gender (P = 0.002), smoking status (P = 0.002), smoking dose (P < 0.001) and histology type (P = 0.015), for rs4809957 among histology type (P = 0.025), for rs247008 among age subgroups (P = 0.006) and for rs9439519 among gender (P = 0.011), smoking status (P = 0.023), smoking dose (P = 0.044) and histology type (P < 0.001) (Supplementary Table 7) . We also performed stratification analyses by three study centers (south China: Guangzhou; central China: Nanjing and Shanghai; and north China: Beijing, Shenyang and Tianjin) (Supplementary Fig. 2 ). We used metaanalyses to combine the results from the three centers and test for heterogeneity. We found similar P values for all five SNPs in the metaanalysis (Supplementary Fig. 2 ). Interaction analyses showed that rs2895680, rs4809957, rs247008 and rs9439519 interacted multiplicatively with smoking dose to contribute to lung cancer risk (interaction P = 1.72 × 10 −10 , P = 5.07 × 10 −3 , P = 6.77 × 10 −3 and P = 4.49 × 10 −2 for rs2895680, rs4809957, rs247008 and rs9439519, respectively) (Supplementary Table 8 ). Further analyses in heavy smokers (pack years > 24) and light smokers (0 < pack years ≤ 24) showed that rs2895680 was significantly associated with smoking dose (OR = 1.09, P = 9.48 × 10 −3 ), but this association was not present for any other SNPs (data not shown).
We also performed expression quantitative trait loci (eQTL) analyses (Online Methods) for these five SNPs. We found that rs247008 was a cis-eQTL of SLC22A5 (encoding solute carrier family 22, member 5; P < 3.96 × 10 −7 , the defined threshold) in a study 11 that measured global gene expression in monocytes in 1,490 unrelated individuals using the Illumina HT-12 v3 BeadChip and that genotyped the subjects using the Affymetrix GenomeWide Human SNP Array 6.0. For SLC22A5, we found 76 cis-eQTLs in the data from that study 11 , and the most significant cis-eQTL was rs2631360 (P = 6.66 × 10 −85 ), which is located 260 kb downstream of rs247008. However, we found no associations with known eQTLs for the four other SNPs. SNP rs1663689 is located 908 kb downstream of the transcription factor GATA3 (encoding GATA binding protein 3) at 10p14. GATA3 is a target for c-Myc and contributes to the development and prognosis of various cancers, including lung cancer [12] [13] [14] . Moreover, GATA3 interacts with BRCA1 and functions as a regulator of tumor initiation by targeting caspase-14, a putative tumor suppressor 15, 16 . In addition, the GATA3 region was reported to be associated with Hodgkin's lymphoma in a previous GWAS 13 . SNP rs2895680 is within intron 2 of STK32A (encoding serine/ threonine kinase 32A) and is between PPP2R2B (encoding protein phosphatase 2, regulatory subunit B, β) and DPYSL3 (encoding dihydropyrimidinase-like 3) at 5q32. STK32A and PPP2R2B encode members of the serine/threonine kinase family that has a paramount role in cellular homeostasis, transcription factor phosphorylation and cell-cycle regulation 17 . PPP2R2B was also previously reported to interact with PDK1 (pyruvate dehydrogenase kinase, isozyme 1) l e t t e r s and antagonize PDK1-Myc signaling to regulate rapamycin sensitivity in cancer 18 . DPYSL3 was previously reported to be a predictor of response to interferon-γ (IFN-γ) in patients with lung cancer after α-galactosylceramide-pulsed treatment of dendritic cells 19 . Notably, our stratification analysis showed that the effect of rs2895680 on lung cancer risk was more pronounced in females, never smokers and lung adenocarcinoma, a pattern similar to genetic variants in the TERT-CLPTM1L locus 20 , although the mechanism behind this is unknown. SNP rs4809957, located in the 3′ untranslated region of CYP24A1 (encoding cytochrome P450, family 24, subfamily a, polypeptide 1/25-hydroxyvitamin D-24-hydroxylase) at 20q13.2, interacted with smoking dose to contribute to lung cancer risk. CYP24A1 is a member of the cytochrome P450 superfamily and is an enzyme that is involved in the metabolism of 1,25-dihydroxyvitamin D3 (1,25(OH) 2 D 3 ). 1,25(OH) 2 D 3 exerts antiproliferative effects on human cancer cells that are mediated by the vitamin D receptor 21 . CYP24A1 was previously reported as a highly probable diagnostic biomarker for non-small-cell lung cancer and is overexpressed in lung tumors 22, 23 . High expression of CYP24A1 also abrogates the antiproliferative effects of 1,25(OH) 2 Although the main effect of the rs247008 variant does not quite reach genome-wide significance, the interaction between this SNP and cigarette smoking suggests that the association might be biologically plausible. The 5q31.1 region is where the T helper type 2 (T H 2) cytokine cluster is located. Extensive evidence has shown a crucial function for T H 2 cytokines in tumor growth, tumor immunogenicity and the host immune response in various cancer types, including lung cancer 26, 27 . Furthermore, the immune response of T H 2 cytokines can be induced by cigarette smoking, which promotes widespread inflammatory and mutagenic effects in the lungs 28, 29 . Among the genes encoding T H 2 cytokines, P4HA2 (encoding prolyl-4 hydoxylase-2), CSF2 (encoding colony stimulating factor 2, also known as GM-CSF) and IL3 (encoding interleukin-3) are near rs247008. The increased production of P4HA2 that is regulated by the tumor suppressor p53 can inhibit angiogenesis and tumor growth, whereas mice with combined loss of IFN-γ, IL-3 and CSF2 develop chronic pulmonary inflammation and lung tumors at high frequencies 30, 31 . In addition, rs247008 is a cis-eQTL for SLC22A5. SLC22A5 encodes a carnitine transporter, and genetic variants in this gene have been reported to be associated with asthma 32 . SLC22A5 is also a direct target of PPAR-α (peroxisomal proliferator-activated nuclear receptor-α) 33 . The expression of PPAR-α changes before the formation of lung tumors, and the activation of PPAR-α favors lung tumor development in vivo 34 . rs247008 is about 99 kb upstream of ACSL6 (encoding acyl-CoA synthetase long-chain family member 6). The expression of ACSL6 mRNA is stimulated by chronic nicotine exposure in vitro and in vivo, and genetic variants in ACSL6 show significant associations with the number of cigarette smoked per day 35 . These findings indicate the potential role of the 5q31.1 region in both lung cancer development and the effects of cigarette smoking.
We also observed an interaction between rs9439519 and cigarette smoking at a borderline significant level. SNP rs9439519 is located at 1p36.32 between AJAP1, encoding adherens junctions associated protein 1, and NPHP4, encoding nephrocystin-4. AJAP1 was recently described as a putative tumor suppressor gene and is involved in the inhibition of cell adhesion and migration 36 . NPHP4 encodes a ciliaassociated protein and acts as a potent negative regulator of Hippo signaling, which has an essential role in tumor suppression and the control of cell proliferation 37 . However, rs9439519 did not reach genome-wide significance in our analyses, and these results should be treated with caution.
In our previous lung cancer GWAS in the Chinese population 1 , we replicated two loci at 3q28 and 5p15.33, which were identified by other GWAS, but not loci at 15q25.1 and 20p12.1. Three additional loci at 3q29 (rs2131877) and 18p11.22 (rs11080466 and rs11663246) were recently identified in a Korean population 8, 9 . However, we did not observe consistent associations in our GWAS data with these three loci. We here identify three new susceptibility loci (5q32, 10p14 and 20q13.2) for lung cancer risk and two additional suggestive loci at 1p36.32 and 5q31.1 in the Chinese population. More crucially, we highlight four genetic modulators (5q32, 20q13.2, 5q31.1 and 1p36.32) of lung cancer risk that interact with cigarette smoking. However, the SNPs analyzed in our study were limited: we did not take SNPs with 1.0 × 10 −4 < P ≤ 1.0 × 10 −2 forward for replication. Further studies are required to provide a more comprehensive 
